Obstetrics
Beckman Coulter Buys Out Royalty Obligation for Preeclampsia Markers
Published in OBGYN and Reproduction Week, September 1st, 2008
Beckman Coulter, Inc. (NYSE:BEC) announced that it signed an agreement to buy out its U.S. royalty obligation to Nephromics LLC, a Chestnut Hill, Mass.-based company focused on women's health. The license is for tests related to the detection, monitoring and risk assessment of preeclampsia, a leading cause of maternal death. In addition, Beckman Coulter obtained rights to acquire the worldwide diagnostics assets of Nephromics.
"Currently, there are no specific in vitro diagnostic tests for preeclampsia, even though the disease threatens the lives of thousands of women and their babies, and places a significant burden on healthcare systems worldwide," said Mike Whelan,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of OBGYN and Reproduction Week
More Articles from OBGYN and Reproduction Week
- Alcoholism
Alcohol dependence among women is linked to delayed childbearing - Bacterial Vaginosis
Studies by B.M. Tavaresmurta and co-authors describe new findings in bacterial vaginosis - Bioengineering
Scientists at Massachusetts General Hospital publish research in bioengineering - Bladder Disease
Reports from K.L. Shek and colleagues advance knowledge in bladder disease - Breast Cancer
New breast cancer data have been reported by H. Roudgari and co-authors - Breast Cancer
Recent findings from Addenbrooke's Hospital highlight research in breast cancer - More from this issue of OBGYN and Reproduction Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
